Gut microbiome and renal transplantation
Authors:
Patrícia Kleinová 1,2; Monika Beliančinová 1,2; Matej Vnučák 1,2; Karol Graňák 1,2; Ivana Dedinská 1,2
Authors‘ workplace:
Transplantačné centrum Univerzitná nemocnica Martin
1; I. interná klinika, Univerzitná nemocnica Martin a Jesseniova lekárska fakulta Univerzity Komenského, Martin
2
Published in:
Vnitř Lék 2023; 69(1): 41-46
Category:
Case reports
doi:
https://doi.org/10.36290/vnl.2023.006
Overview
Gut microbiome research has been a surge of interest in many branches of medicine in the last decade. Our main aim is to show ability of microbes to infuence the functions of human body, especially in the immune system, and on the other hand to clarify changes in composition of gut microbiome in the post-transplantation period and their function for the long-term survival of the graft and the patient in the context of the occurrence of a wide range of complications.
Kidney transplantation with the subsequent use of immunosuppressants and antibiotics affects the composition of gut microbiome. The subsequent development of dysbiosis significantly increases the risk of acute rejection, interstitial fibrosis and tubular atrophy of the graft, post-transplant diarrhoea, organ´s infections and metabolic complications such as post-transplant diabetes mellitus.
Also important is the influence of the microorganisms of the gut microbiome on metabolism of immunosuppressants with the production of less effective components and the subsequent necessity of modifying their levels with a higher risk of underdosing and the occurrence of graft rejection. Support of the composition of the gut microbiome in the post-transplantation period in favor of bacteria producing short chain fatty acids (SCFA) is possible by changing of diet with predominance of fiber, the application of probiotics, prebiotics.
According to available studies, it can lead to benefits in term of metabolic compensation, to the induction of donor-specific tolerance and many others, with an overall improvement in the quality of patient and graft survival.
Keywords:
dysbiosis – kidney transplantation – gut microbiome – immunosuppressants – SCFA
Sources
1. Salvadori M, Tsalouchos A. The Microbiota and Kidney Transplantation: Influence on the Graft. EMJ Urol. 2021;9(1):95-106.
2. Berg G, Rybakova, D, Fischer, D, et al. Microbiome definition re‑visited: old concepts and new challenges. Microbiome 8, 103 (2020). https://doi.org/10.1186/s40168-020-00875-0
3. Lee SH. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest Res. 2015;13(1):11-8.
4. Rowland I, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57(1):1-24.
5. Valde AM, et al. Role of the gut microbiota in nutrition and health. BMJ 2018;361:k2179
6. Kiepura A, et al. Anti‑atherosclerotic potential of free fatty acid receptor 4 (FFAR4). Biomedicines. 2021;9(5):467.
7. Tang WH, Wang Z, Kennedy DJ, et al. Gut microbiota‑dependent trimethylamine N‑oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015; 116: 448-455 [PMID: 25599331 DOI: 10.1161/ CIRCRESAHA.116.305360]
8. Satoh M, Hayashi H, Watanabe M, et al. Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure. Nephron Exp Nephrol. 2003; 95: e111-e118 [PMID: 14646363 DOI: 10.1159/000074327].
9. Guo TL, Chen Y, Xu HS, et al. Gut microbiome in neuroendocrine and neuroimmune interactions: The case of genistein. Toxicol Appl Pharmacol. 2020; 402: 115130 [PMID: 32673657 DOI: 10.1016/j.taap.2020.115130].
10. Ahmad S, Bromberg J. Current status of the microbiome in renal transplantation. Curr Opin Nephrol Hypertens. 2016 November; 25(6):570–576. doi:10.1097/ MNH.0000000000000262.
11. Human CD4+ T helper cells. Miltenyi Biotec. [cit. 2023–01–14]. Available from: https:// www.miltenyibiotec.com/DE‑en/ resources/macs‑handbook/ human‑cells‑and‑organs/ human‑cell‑types/ cd4-t‑cells‑human. html
12. Sabihi M, Böttcher M, Pelczar P, et al. Microbiota‑Dependent Effects of IL-22. Cells. 2020 Oct; 9(10): 2205. doi: 10.3390/cells9102205
13. Wang W, et al. Gut microbiota and allogeneic transplantation. J Transl Med. 2015;13:275.
14. Lee JR, Muthukumar T, Dadhania D, et al. Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation. 2014;98:697- 705 [PMID: 25289916 DOI: 10.1097/TP.0000000000000370].
15. Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33:496-503 [PMID: 26210164 DOI: 10.1016/j.tibtech. 2015. 06. 011]
16. Bromberg JS, et al. Microbiota – implications for immunity and transplantation. Nat Rev Nephrol. 2015;11(6):342-53.
17. Salvadori M, Tsalouchos A. Microbiota, renal disease and renal transplantation. World J Transplant. 2021 March 18;11(3):16-36.
18. Modena BD, Milam R, Harrison F, et al. Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. Am J Transplant. 2017;17:712-723 [PMID: 27597148 DOI: 10.1111/ajt.14038].
19. Fricke WF, Maddox C, Song Y, et al. Human microbiota characterization in the course of renal transplantation. Am J Transplant. 2014;14:416-427 [PMID: 24373208 DOI: 10.1111/ ajt.12588].
20. Chan S, et al. Transplant associated infections – the role of the gastrointestinal microbiota and potential therapeutic options. Nephrology (Carlton). 2020;25(1):513.
21. Lee JR, Magruder M, Zhang L, et al. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. Am J Transplant. 2019;19:488-500 [PMID: 29920927 DOI: 10.1111/ ajt.14974].
22. Biehl LM, Cruz Aguilar R, Farowski F, et al. Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection. Infection. 2018;46:871-874 [PMID: 30109576 DOI: 10.1007/s15010-018-1190-9].
23. Bunnapradist S, Neri L, Wong W, et al. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis. 2008;51:478-486 [PMID: 18295064 DOI: 10.1053/j.ajkd.2007. 11. 013].
24. Zhang LT, et al. Gut microbiota profiles and fecal beta‑glucuronidase activity in kidney transplant recipients with and without post‑transplant diarrhea. Clin Transplant. 2021:e14260.
25. Kelly CR, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent clostridium difficile infection: a randomized trial. Ann Intern Med. 2016;165(9):609-16.
26. Lee JR, Muthukumar T, Dadhania D, et al. Gut microbiota and tacrolimus dosing in kidney transplantation. PloS One 2015; 10: e0122399 [PMID: 25815766 DOI: 10.1371/journal. pone.0122399].
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2023 Issue 1
Most read in this issue
- Histamine intolerance
- What is new in 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non‑cardiac surgery
- Differential diagnosis of increased Erythrocyte Sedimentation rate
- Dental interventions in oral antithrombotic therapy